drugset / Trial / NCT07512427
Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants
RandomizedParallel-groupTriple-blindTreatment
Summary
Two-part Phase 1/2 study of OPK-88006, including an open-label SAD phase in healthy participants and a double-blind, randomized, placebo-controlled MAD phase in participants with presumed MASH, to evaluate safety, PK, and MASH related pharmacodynamic changes compared to placebo.
Timeline
- Start
- 2026-12
- Primary completion
- 2027-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OPK-88006 | Unknown | — | Subcutaneous |
Indications
No indication recorded.